Natalizumab Completed Phase N/A Trials for Relapsing Remitting Multiple Sclerosis (RRMS)

IndicationsStatusPurposePhase
CompletedNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
https://clinicaltrials.gov/ct2/show/Clinical Disease Activity With Long Term Natalizumab Treatment
https://clinicaltrials.gov/ct2/show/Real-world Outcomes on Tecfidera (BG00012, Dimethyl Fumarate) Post-Tysabri (BG00002, Natalizumab)
https://clinicaltrials.gov/ct2/show/Ireland Natalizumab (TYSABRI) Observational Program
https://clinicaltrials.gov/ct2/show/Observational Study of Tysabri in Early Relapsing-Remitting Multiple Sclerosis in Anti-JC Virus Antibody Negative Participants
https://clinicaltrials.gov/ct2/show/A Proof of Concept Study to Evaluate the Effectiveness of Tysabri in Relapsing Remitting Multiple Sclerosis (RRMS) Patient Bladder Function